InsiderTrades.com logo

LGND Insider Trading

Insider Ownership Percentage: 7.00%
Insider Buying (Last 12 Months): $1,156,542.00
Insider Selling (Last 12 Months): $3,539,884.56

Ligand Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Ligand Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Ligand Pharmaceuticals Share Price & Price History

Current Price: $190.44
Price Change: ▼ Price Decrease of -1.25 (-0.65%)
As of 02/6/2026 05:00 PM ET

This chart shows the closing price history over time for LGND up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Ligand Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/2/2026John W. KozarichDirectorSell467$195.91$91,489.9743,187View SEC Filing Icon  
1/2/2026John W. KozarichDirectorSell467$189.58$88,533.8643,654View SEC Filing Icon  
12/12/2025Octavio EspinozaCFOSell1,804$188.31$339,711.2426,186View SEC Filing Icon  
12/1/2025John W. KozarichDirectorSell467$195.84$91,457.2844,121View SEC Filing Icon  
11/3/2025John W. KozarichDirectorSell467$191.05$89,220.3544,588View SEC Filing Icon  
10/1/2025John W. KozarichDirectorSell467$179.44$83,798.4845,055View SEC Filing Icon  
9/23/2025Jason AryehDirectorSell10,000$170.81$1,708,100.0069,289View SEC Filing Icon  
9/2/2025John W. KozarichDirectorSell467$162.26$75,775.4245,522View SEC Filing Icon  
8/1/2025John W. KozarichDirectorSell467$131.88$61,587.9645,989View SEC Filing Icon  
7/10/2025John W. KozarichDirectorSell934$125.00$116,750.0046,456View SEC Filing Icon  
6/23/2025Andrew ReardonInsiderSell500$114.08$57,040.0031,903View SEC Filing Icon  
6/10/2025Andrew ReardonInsiderSell500$114.54$57,270.0032,403View SEC Filing Icon  
5/15/2025Andrew ReardonInsiderSell1,000$104.00$104,000.0032,903View SEC Filing Icon  
5/9/2025Octavio EspinozaCFOBuy1,500$104.06$156,090.0027,932View SEC Filing Icon  
5/9/2025Todd C. DavisCEOBuy9,510$105.20$1,000,452.00161,234View SEC Filing Icon  
3/4/2025Octavio EspinozaCFOSell5,000$115.03$575,150.0018,879View SEC Filing Icon  
12/23/2024Octavio EspinozaCFOSell2,104$116.37$244,842.4820,647View SEC Filing Icon  
11/27/2024John L. LaMattinaDirectorSell2,406$123.65$297,501.9029,515View SEC Filing Icon  
9/23/2024Andrew ReardonInsiderSell2,000$99.60$199,200.0022,534View SEC Filing Icon  
9/23/2024Matthew E KorenbergCOOSell9,772$101.22$989,121.8450,777View SEC Filing Icon  
9/20/2024Matthew E KorenbergCOOSell6,275$104.10$653,227.5050,777View SEC Filing Icon  
9/20/2024Octavio EspinozaCFOSell1,275$103.94$132,523.5024,610View SEC Filing Icon  
8/28/2024Andrew ReardonInsiderSell1,500$106.39$159,585.0022,534View SEC Filing Icon  
8/26/2024Matthew E KorenbergCOOSell11,389$105.61$1,202,792.2949,510View SEC Filing Icon  
8/22/2024Matthew E KorenbergCOOSell1,157$105.54$122,109.7867,211View SEC Filing Icon  
8/9/2024Matthew E KorenbergCOOSell18,245$98.50$1,797,132.5068,368View SEC Filing Icon  
8/8/2024Todd C. DavisCEOBuy2,500$97.39$243,475.00123,010View SEC Filing Icon  
5/17/2024Octavio EspinozaCFOSell5,156$86.66$446,818.9623,379View SEC Filing Icon  
5/15/2024Octavio EspinozaCFOSell5,873$86.01$505,136.7323,882View SEC Filing Icon  
5/13/2024Matthew E KorenbergInsiderSell3,440$84.54$290,817.60100,421View SEC Filing Icon  
5/9/2024Andrew ReardonInsiderSell10,000$83.04$830,400.0022,205View SEC Filing Icon  
5/9/2024Nancy Ryan GrayDirectorSell934$83.20$77,708.805,633View SEC Filing Icon  
3/5/2024Stephen L. SabbaDirectorSell1,893$74.30$140,649.9028,926View SEC Filing Icon  
2/28/2024Octavio EspinozaCFOSell140$88.46$12,384.4029,755View SEC Filing Icon  
9/22/2023Todd C. DavisCEOBuy4,000$59.38$237,520.0073,090View SEC Filing Icon  
5/16/2023John W. KozarichDirectorSell4,444$77.20$343,076.8038,488View SEC Filing Icon  
5/10/2023Stephen L. SabbaDirectorSell6,408$77.13$494,249.0425,784View SEC Filing Icon  
5/8/2023John W. KozarichDirectorSell6,408$76.56$490,596.4842,213View SEC Filing Icon  
3/24/2023Andrew ReardonInsiderSell300$69.92$20,976.0016,308View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Ligand Pharmaceuticals (NASDAQ:LGND)

91.28% of Ligand Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LGND by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Ligand Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/6/2026Global Retirement Partners LLC418$79K0.0%+77.1%0.002%Search for SEC Filing on Google Icon
2/6/2026IFP Advisors Inc342$65K0.0%+1,040.0%0.002%Search for SEC Filing on Google Icon
2/6/2026Covestor Ltd343$65K0.0%+17,050.0%0.002%Search for SEC Filing on Google Icon
2/6/2026PNC Financial Services Group Inc.2,240$0.42M0.0%+22.4%0.011%Search for SEC Filing on Google Icon
2/6/2026ProShare Advisors LLC4,640$0.88M0.0%+7.9%0.024%Search for SEC Filing on Google Icon
2/6/2026Envestnet Portfolio Solutions Inc.1,407$0.27M0.0%-9.8%0.007%Search for SEC Filing on Google Icon
2/5/2026Stephens Investment Management Group LLC501,040$94.73M1.2%-9.6%2.546%Search for SEC Filing on Google Icon
2/5/2026Dana Investment Advisors Inc.69,396$13.12M0.4%-4.5%0.353%Search for SEC Filing on Google Icon
2/5/2026Northwestern Mutual Wealth Management Co.146,349$27.67M0.0%+385,028.9%0.744%Search for SEC Filing on Google Icon
2/5/2026Isthmus Partners LLC24,708$4.67M0.5%-16.2%0.126%Search for SEC Filing on Google Icon
2/5/2026Thrivent Financial for Lutherans13,525$2.56M0.0%-4.3%0.069%Search for SEC Filing on Google Icon
2/4/2026VIRGINIA RETIREMENT SYSTEMS ET Al1,500$0.28M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/4/2026Pier 88 Investment Partners LLC8,520$1.61M0.4%+18.3%0.043%Search for SEC Filing on Google Icon
2/4/2026Swiss Life Asset Management Ltd1,823$0.35M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/3/2026F m Investments LLC46,130$8.72M0.3%-10.4%0.234%Search for SEC Filing on Google Icon
2/3/2026Crossmark Global Holdings Inc.2,264$0.43M0.0%+25.2%0.012%Search for SEC Filing on Google Icon
2/3/2026Equitable Trust Co.5,035$0.95M0.0%-14.9%0.026%Search for SEC Filing on Google Icon
2/2/2026Strs Ohio6,100$1.15M0.0%-6.2%0.031%Search for SEC Filing on Google Icon
2/2/2026Kornitzer Capital Management Inc. KS60,342$11.41M0.2%-33.8%0.307%Search for SEC Filing on Google Icon
2/2/2026Oppenheimer Asset Management Inc.1,183$0.22M0.0%N/A0.006%Search for SEC Filing on Google Icon
1/30/2026Sigma Planning Corp3,000$0.57M0.0%N/A0.015%Search for SEC Filing on Google Icon
1/30/2026State of New Jersey Common Pension Fund D6,689$1.27M0.0%-50.5%0.034%Search for SEC Filing on Google Icon
1/30/2026Moody Aldrich Partners LLC19,581$3.70M0.7%-24.4%0.099%Search for SEC Filing on Google Icon
1/30/2026Keybank National Association OH1,477$0.28M0.0%+11.1%0.008%Search for SEC Filing on Google Icon
1/29/2026Comerica Bank5,432$1.03M0.0%-16.9%0.028%Search for SEC Filing on Google Icon
1/29/2026Ashton Thomas Private Wealth LLC2,103$0.40M0.0%+4.4%0.011%Search for SEC Filing on Google Icon
1/29/2026Pictet Asset Management Holding SA64,386$12.55M0.0%-3.9%0.327%Search for SEC Filing on Google Icon
1/29/2026Supplemental Annuity Collective Trust of NJ1,290$0.24M0.1%-32.1%0.007%Search for SEC Filing on Google Icon
1/29/2026UBS Group AG143,067$27.05M0.0%+27.8%0.727%Search for SEC Filing on Google Icon
1/29/2026Teachers Retirement System of The State of Kentucky4,791$0.91M0.0%-2.3%0.024%Search for SEC Filing on Google Icon
1/29/2026Vanguard Group Inc.2,073,892$392.11M0.0%-0.1%10.538%Search for SEC Filing on Google Icon
1/29/2026Impax Asset Management Group plc165,208$31.24M0.2%-17.5%0.839%Search for SEC Filing on Google Icon
1/29/2026Calamos Advisors LLC21,045$3.98M0.0%+1.5%0.107%Search for SEC Filing on Google Icon
1/29/2026China Universal Asset Management Co. Ltd.3,207$0.61M0.0%-6.6%0.016%Search for SEC Filing on Google Icon
1/28/2026Arizona State Retirement System5,506$1.04M0.0%-3.4%0.028%Search for SEC Filing on Google Icon
1/28/2026B. Metzler seel. Sohn & Co. AG6,879$1.30M0.0%N/A0.035%Search for SEC Filing on Google Icon
1/28/2026Villere ST Denis J & Co. LLC202,452$38.28M3.8%-27.7%1.029%Search for SEC Filing on Google Icon
1/28/2026Universal Beteiligungs und Servicegesellschaft mbH20,902$3.95M0.0%-4.3%0.106%Search for SEC Filing on Google Icon
1/27/2026Bayforest Capital Ltd385$73K0.1%N/A0.002%Search for SEC Filing on Google Icon
1/27/2026First Horizon Corp574$0.11M0.0%+114.2%0.003%Search for SEC Filing on Google Icon
1/26/2026Chicago Capital LLC561,423$106.15M2.6%-1.3%2.852%Search for SEC Filing on Google Icon
1/26/2026Mirae Asset Global Investments Co. Ltd.956$0.18M0.0%+26.1%0.005%Search for SEC Filing on Google Icon
1/23/2026Assetmark Inc.6,191$1.17M0.0%+4,933.3%0.031%Search for SEC Filing on Google Icon
1/23/2026State of Alaska Department of Revenue13,649$2.58M0.0%+25.3%0.069%Search for SEC Filing on Google Icon
1/23/2026Choreo LLC1,404$0.27M0.0%-13.2%0.007%Search for SEC Filing on Google Icon
1/23/2026Gibbs Wealth Management3,348$0.69M0.2%-47.2%0.017%Search for SEC Filing on Google Icon
1/22/2026Massachusetts Financial Services Co. MA507,019$95.86M0.0%-6.4%2.576%Search for SEC Filing on Google Icon
1/21/2026Yousif Capital Management LLC5,402$1.06M0.0%-12.2%0.027%Search for SEC Filing on Google Icon
1/21/2026Portside Wealth Group LLC2,833$0.54M0.1%-32.8%0.014%Search for SEC Filing on Google Icon
1/21/2026Sowell Financial Services LLC1,328$0.25M0.0%N/A0.007%Search for SEC Filing on Google Icon
1/16/2026Aberdeen Group plc119,309$22.56M0.0%-37.1%0.606%Search for SEC Filing on Google Icon
1/16/2026Ellsworth Advisors LLC6,565$1.29M0.3%-6.7%0.033%Search for SEC Filing on Google Icon
1/16/2026Linden Thomas Advisory Services LLC16,575$3.13M0.3%-1.4%0.084%Search for SEC Filing on Google Icon
1/15/2026BTC Capital Management Inc.2,143$0.41M0.0%-28.5%0.011%Search for SEC Filing on Google Icon
1/15/2026Nisa Investment Advisors LLC730$0.14M0.0%-8.5%0.004%Search for SEC Filing on Google Icon
1/15/2026Allspring Global Investments Holdings LLC71,818$13.65M0.0%-33.8%0.365%Search for SEC Filing on Google Icon
1/14/2026USA Financial Formulas227$43K0.0%N/A0.001%Search for SEC Filing on Google Icon
1/13/2026Norden Group LLC1,321$0.25M0.0%-36.9%0.007%Search for SEC Filing on Google Icon
1/12/2026Contravisory Investment Management Inc.2,036$0.39M0.1%-6.6%0.010%Search for SEC Filing on Google Icon
1/9/2026Congress Asset Management Co.480,063$90.77M0.6%-28.1%2.439%Search for SEC Filing on Google Icon
1/9/2026SG Americas Securities LLC10,817$2.05M0.0%-7.7%0.055%Search for SEC Filing on Google Icon
1/8/2026Wealth Enhancement Advisory Services LLC2,688$0.53M0.0%+3.0%0.014%Search for SEC Filing on Google Icon
1/8/2026Nordea Investment Management AB53,725$10.19M0.0%-11.9%0.273%Search for SEC Filing on Google Icon
1/5/2026Park Avenue Securities LLC1,402$0.27M0.0%N/A0.007%Search for SEC Filing on Google Icon
1/1/2026JPMorgan Chase & Co.39,718$7.04M0.0%+4.5%0.202%Search for SEC Filing on Google Icon
12/9/2025Tudor Investment Corp ET AL15,750,000$2.79B1.7%N/A80.030%Search for SEC Filing on Google Icon
11/25/2025Court Place Advisors LLC5,158$0.91M0.3%-1.9%0.026%Search for SEC Filing on Google Icon
11/24/2025Penn Capital Management Company LLC107,282$19.02M1.5%-10.9%0.545%Search for SEC Filing on Google Icon
11/24/2025CIBC Private Wealth Group LLC149$26K0.0%+86.3%0.001%Search for SEC Filing on Google Icon
11/21/2025CIBC Bancorp USA Inc.2,034$0.36M0.0%N/A0.010%Search for SEC Filing on Google Icon
11/20/2025Wilmington Savings Fund Society FSB1,082$0.19M0.0%-8.5%0.005%Search for SEC Filing on Google Icon
11/19/2025Captrust Financial Advisors15,009$2.66M0.0%-3.8%0.076%Search for SEC Filing on Google Icon
11/18/2025Acuitas Investments LLC13,494$2.39M1.5%-32.2%0.069%Search for SEC Filing on Google Icon
11/18/2025Cim Investment Management Inc.1,435$0.25M0.1%N/A0.007%Search for SEC Filing on Google Icon
11/17/2025Jacobs Levy Equity Management Inc.127,689$22.62M0.1%-21.6%0.649%Search for SEC Filing on Google Icon
11/17/2025Castleark Management LLC64,676$11.46M0.3%N/A0.329%Search for SEC Filing on Google Icon
11/17/2025CANADA LIFE ASSURANCE Co23,299$4.03M0.0%+1.5%0.118%Search for SEC Filing on Google Icon
11/17/2025Caxton Associates LLP14,508$2.57M0.1%N/A0.074%Search for SEC Filing on Google Icon
11/17/2025Verition Fund Management LLC4,863$0.86M0.0%-65.7%0.025%Search for SEC Filing on Google Icon
11/17/2025Susquehanna Fundamental Investments LLC1,184$0.21M0.0%N/A0.006%Search for SEC Filing on Google Icon
11/17/2025Private Capital Management LLC227,158$40.24M3.6%-0.9%1.154%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd3,632$0.64M0.0%-79.9%0.018%Search for SEC Filing on Google Icon
11/17/2025Nomura Holdings Inc.121,363$21.50M0.0%N/A0.617%Search for SEC Filing on Google Icon
11/17/2025Mariner LLC1,537$0.27M0.0%N/A0.008%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.8,869$1.57M0.0%-15.2%0.045%Search for SEC Filing on Google Icon
11/17/2025JPL Wealth Management LLC296$52K0.0%N/A0.002%Search for SEC Filing on Google Icon
11/17/2025Gotham Asset Management LLC9,475$1.68M0.0%N/A0.048%Search for SEC Filing on Google Icon
11/17/2025Granahan Investment Management LLC24,962$4.42M0.2%N/A0.127%Search for SEC Filing on Google Icon
11/17/2025Fred Alger Management LLC5,868$1.04M0.0%N/A0.030%Search for SEC Filing on Google Icon
11/17/2025Clark Capital Management Group Inc.82,991$14.70M0.1%+16.7%0.422%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE122,409$21.68M0.0%+5.7%0.622%Search for SEC Filing on Google Icon
11/17/2025Aquatic Capital Management LLC6,598$1.17M0.0%N/A0.034%Search for SEC Filing on Google Icon
11/17/2025Alliancebernstein L.P.22,253$3.94M0.0%+7.6%0.113%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.101,243$17.93M0.0%-7.7%0.514%Search for SEC Filing on Google Icon
11/14/2025Creative Planning6,112$1.08M0.0%+28.7%0.031%Search for SEC Filing on Google Icon
11/14/2025Ashford Capital Management Inc.244,430$43.30M4.8%-19.2%1.242%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.18,860$3.34M0.0%-6.2%0.096%Search for SEC Filing on Google Icon
11/14/2025Amundi3,356$0.61M0.0%+7.3%0.017%Search for SEC Filing on Google Icon
11/14/2025Equitable Holdings Inc.8,836$1.57M0.0%+26.1%0.045%Search for SEC Filing on Google Icon
11/14/2025California State Teachers Retirement System18,311$3.24M0.0%-4.1%0.093%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Ligand Pharmaceuticals logo
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, engages in the development and licensing of biopharmaceutical assets worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; Filspari, a dual endothelin and angiotensin II receptor antagonist in development for rare kidney diseases and non-immunosuppressive treatment indicated for immunoglobulin A nephropathy; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by streptococcus pneumoniae serotypes; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and children aged 8 years and older with Stage 2 T1D; Nexterone, a captisol-enabled formulation of amiodarone; Zulresso, a captisol-enabled formulation of brexanolone for the treatment of postpartum depression; and Veklury, an antiviral treatment for moderate or severe COVID-19. In addition, it provides Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of post-menopausal symptoms in women; Exemptia for autoimmune diseases; Vivitra for breast cancer; and Bryxta and Zybev for various indications. The company has alliances, licenses, and other business relationships with Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences, and Baxter International. Further, it sells Captisol materials. Ligand Pharmaceuticals Incorporated was incorporated in 1987 and is based in Jupiter, Florida.
Read More on Ligand Pharmaceuticals

Today's Range

Now: $190.44
Low: $189.17
High: $197.00

50 Day Range

MA: $194.44
Low: $183.13
High: $206.81

52 Week Range

Now: $190.44
Low: $93.58
High: $212.49

Volume

272,766 shs

Average Volume

234,434 shs

Market Capitalization

$3.75 billion

P/E Ratio

92.00

Dividend Yield

N/A

Beta

1.14

Who are the company insiders with the largest holdings of Ligand Pharmaceuticals?

Ligand Pharmaceuticals' top insider investors include:
  1. Todd C Davis (CEO)
  2. Matthew E Korenberg (Insider)
  3. Jason Aryeh (Director)
  4. Matthew E Korenberg (COO)
  5. John W Kozarich (Director)
  6. Andrew Reardon (Insider)
  7. Octavio Espinoza (CFO)
  8. John L Lamattina (Director)
  9. Stephen L Sabba (Director)
  10. Nancy Ryan Gray (Director)
Learn More about top insider investors at Ligand Pharmaceuticals.

Who are the major institutional investors of Ligand Pharmaceuticals?

Ligand Pharmaceuticals' top institutional investors include:
  1. Vanguard Group Inc. — 10.54%
  2. Chicago Capital LLC — 2.85%
  3. Massachusetts Financial Services Co. MA — 2.58%
  4. Stephens Investment Management Group LLC — 2.55%
  5. Congress Asset Management Co. — 2.44%
  6. Villere ST Denis J & Co. LLC — 1.03%
Learn More about top institutional investors of Ligand Pharmaceuticals stock.

Which institutional investors are selling Ligand Pharmaceuticals stock?

In the previous quarter, LGND stock was sold by these institutional investors:
  1. Congress Asset Management Co.
  2. Villere ST Denis J & Co. LLC
  3. Aberdeen Group plc
  4. Stephens Investment Management Group LLC
  5. Allspring Global Investments Holdings LLC
  6. Impax Asset Management Group plc
  7. Massachusetts Financial Services Co. MA
  8. Kornitzer Capital Management Inc. KS
During the previous year, company insiders that have sold Ligand Pharmaceuticals company stock include:
  1. Todd C Davis (CEO)
  2. Matthew E Korenberg (Insider)
  3. Jason Aryeh (Director)
  4. Matthew E Korenberg (COO)
Learn More investors selling Ligand Pharmaceuticals stock.

Which institutional investors are buying Ligand Pharmaceuticals stock?

During the previous quarter, LGND stock was acquired by institutional investors including:
  1. Northwestern Mutual Wealth Management Co.
  2. UBS Group AG
  3. B. Metzler seel. Sohn & Co. AG
  4. Assetmark Inc.
  5. Sigma Planning Corp
  6. State of Alaska Department of Revenue
  7. Swiss Life Asset Management Ltd
  8. VIRGINIA RETIREMENT SYSTEMS ET Al
Within the last year, these company insiders have bought Ligand Pharmaceuticals stock:
  1. Todd C Davis (CEO)
  2. Matthew E Korenberg (Insider)
Learn More investors buying Ligand Pharmaceuticals stock.